<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03692845</url>
  </required_header>
  <id_info>
    <org_study_id>6272829</org_study_id>
    <nct_id>NCT03692845</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion</brief_title>
  <official_title>Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study that compares between Open TLIF and Minimally invasive TLIF regarding patients'
      functional status(Oswestry Disability index)as a primary outcome measure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oswestry Disability index(Arabic version) 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>â€¢ Fusion rate as assessed by Bridwell fusion score.</measure>
    <time_frame>1 year</time_frame>
    <description>Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spinal Fusion</condition>
  <arm_group>
    <arm_group_label>O-TLIF group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Spinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MI-TLIF group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Spinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transforaminal Lumbar Interbody Fusion either open or minimally invasive</intervention_name>
    <description>Spinal fusion procedure through the intervertebral foramen</description>
    <arm_group_label>MI-TLIF group</arm_group_label>
    <arm_group_label>O-TLIF group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults more than 18 years of age and less than 65 years of age..

          -  Degenerative or isthmic spondylolithesis Grade 1,2 and 3.

          -  Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural
             compression.

          -  Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.

          -  Symptoms not responding to conservative treatment for at least 3 months.

        Exclusion Criteria:

          -  Previous spinal fusion or instrumentation.

          -  Spinal tumours, infection and fractures.

          -  Patients with severe osteoporosis

          -  BMI more than 35.

          -  Non-ambulant patients and patients with severe preoperative neurological affection
             (Cauda Equina Syndrome)

          -  Patients not willing to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2018</study_first_posted>
  <last_update_submitted>October 1, 2018</last_update_submitted>
  <last_update_submitted_qc>October 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Amr Hatem Ahmed Mohammed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>spine fusion</keyword>
  <keyword>minimally invasive surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

